Biotechnological Production of Lignans 153
potential botanical supplement for the medical management of nuclear and radiological
emergencies. J Dietary Supplements 7(1), 31–50.
Arora, R., Gupta, D., Chawla, R., Adhikari, M., Sharma, J., Dhaker, A.S., Goyal, V., Kumar, R.,
Sharma, A., Sharma, R.K., Tripathi, R.P. and Puri, S.C. (2010b) Antioxidant, Anticancer,
Cytoprotective and Radioprotective Properties of Indian P. hexandrum. In: Arora, R. (ed.)
Herbal Medicine: A Cancer Chemopreventive and Therapeutic Perspective, Jaypee Brothers
Medical Publishers (P) Ltd., Delhi, India, pp. 616-630.
Arora, R., Singh, S., Puri, S.C. and Sharma, R.K. (2008) Himalayan Mayapple (Podophyllum
hexandrum Royle): Traditional Uses, Clinical Indications and Future Prospects. In: Watson, R.
and Preedy, V.R. (eds) Botanical Medicine in Clinical Practice. CABI Publishing, Wallingford,
Oxon, United Kingdom, pp. 71–84.
Ayres, D.C. and Loike, J. (1990) Lignans, Chemical, Biological and Clinical Properties. Cambridge
University Press, Oxford, pp. 85–90.
Bedir, E., Khan, I. and Moraes, R.M. (2002) Bioprospecting for podophyllotoxin. In: Janick J. and
Whipkey, A. (eds) Trends in New Crops and New Uses. ASHS Press, Alexandria, VA, pp. 545–
549.
Broomhead, A.J. and Dewick, P.M. (1990a) Aryltetralin lignans from Linum flavum and Linum
capitatum. Phytochemistry 29, 3839–3844.
Broomhead, A.J. and Dewick, P.M. (1990b) Tumour-inhibitory aryltetralin lignans in Podophyllum
versipelle, Diphylleia cymosa and I. Phytochemistry 29, 3831–3837.
Canel, C., Moraes, R.M., Dayan, F.E. and Ferreira, D. (2000) Molecules of interest
‘Podophyllotoxin’. Phytochemistry 54, 115–120.
Chattopadhyay, S., Bisaria, V.S., Panda, A.K. and Srivastava, A.K. (2004) Cytotoxicity of in vitro
produced podophyllotoxin from Podophyllum hexandrum on human cancer cell line. Natural
Product Research 18, 51–57.
Chattopadhyay, S., Srivastava, A.K., Bhojwani, S.S. and Bisaria, V.S. (2002) Production of
Podophyllotoxin by plant cell cultures of Podophyllum hexandrum in bioreactor. Journal of
Bioscience and Bioengineering 93(2), 215–220.
Chawla, R., Arora, R., Singh, S., Sagar, R.K., Sharma, R.K., Kumar, R., Sharma, A., Tripathi, R.P.,
Puri, S.C., Khan, H.A., Shawl, A.S., Sultan, P.S., Krishen, T. and Qazi, G.N. (2006)
Podophyllum hexandrum offers radioprotection by modulating free radical flux: Role of aryl-
tetralin lignans. Evidence Based Complementary and Alternative Medicine 3(4), 503–511.
Cockayne, T.O. (1961) Leech book of Bald, In: Cockayne, T.O. (ed) Leechdom, Wortcunnings and
Starcraft of Early England. The Holland Press, London, pp. 313.
Dechamp, J., (1999) Herbal medicinal products and patents need in Europe. Drug Information
Journal 33, 309–313.
Dewick, P.M. (1994) Forsythia species: in vitro culture and the production of lignans and other
secondary metabolites. In: Bajaj, Y.P.S. (ed.) Biotechnology in Agriculture and Forestry
.
Springer Verlag, Berlin/Heidelberg, pp. 236–256.
Empt, U., Alfermann, A.W
., Pras, N. and Petersen, M., (2000) The use of plant cell cultures for the
production of podophyllotoxin and related lignans. Journal of Applied Botany 74, 145–150.
Fuss, E. (2003) Lignans in plant cell and organ cultures. Phytochemistry Review 2, 307–320.
Gupta, R. and Sethi, K.L. (1983) Conservation of medicinal plant resources in the Himalayan region.
In: Jain, S.K. and Mehra, K.L. (eds) Conservation of Tropical Plant Resources. Botanical
Survey of India, Howrah, India, pp. 101–107.
Howarth, R.D. (1936) Natural resins. Annual Report Progress Chemistry 33, 266–279.
Imbert, F. (1998) Discovery of podophyllotoxins. Biochimie 80, 207–222.
Ionkova, I. (2007) Biotechnological approaches for the production of lignans. Pharmacognosy
Reviews 1(1), 57–68.
Ionkova, I., Antonova, I., Momekov, G. and Fuss, E. (2007) Cytotoxic activity of extracts from
Bulgarian Linum species. Pharmacognosy Magazine 3(1), 192–195.
Ionkova, I., Goermova, B., Vasilev, N. and Fuss, E. (2006) Lignan production in cell cultures of
Linum tauricum ssp. Tauricum. Proceedings of IV Balkan Botanical Congress, 661–664.